Anthocyanin Supplements Reverse Prediabetes in 56% of Participants Within 12 Weeks

This groundbreaking study demonstrates that anthocyanin supplementation can effectively reverse prediabetes, offering hope for millions at risk of developing type 2 diabetes. Prediabetes affects nearly one-third of adults and significantly increases diabetes and cardiovascular disease risk.

Researchers conducted a rigorous 12-week randomized, double-blind, placebo-controlled trial with 68 participants who had impaired glucose tolerance. Half received 160mg daily anthocyanin supplements while the other half took placebo, alongside standard lifestyle guidance.

The results were remarkable: 56% of anthocyanin users achieved normal glucose tolerance compared to only 29% in the placebo group. The supplements improved insulin sensitivity significantly, as measured by the Matsuda index. Importantly, participants also showed reduced skin advanced glycation end products (AGEs), which are harmful compounds linked to aging and metabolic dysfunction.

For longevity enthusiasts, this research is particularly exciting because it addresses multiple aging pathways simultaneously. Improved glucose metabolism and reduced AGE formation both contribute to healthier aging and reduced disease risk. The correlation between AGE reduction and glucose improvements suggests anthocyanins work through fundamental anti-aging mechanisms.

However, the study has limitations. The sample size was relatively small, and the 12-week duration doesn't establish long-term effects. The specific anthocyanin formulation used may not be equivalent to dietary sources like blueberries or blackberries. Additionally, all participants received lifestyle guidance, making it unclear how anthocyanins would perform alone. Despite these caveats, the results strongly support anthocyanins as a valuable tool for metabolic health optimization and diabetes prevention.